Obstacles and opportunities in new drug ... [Clin Pharmacol Ther. 2008] - PubMed

Balancing US patent and FDA approval processes: strategically optimizing market exclusivity. [Drug Discov Today. 2004]
Balancing US patent and FDA approval processes: strategically optimizing market exclusivity.
Fernandez DS, Huie JT. Drug Discov Today. 2004 Jun 15; 9(12):509-12.
Good drug, bad luck: business, regulatory issues can create obstacles for drug development. [J Natl Cancer Inst. 2004]
Good drug, bad luck: business, regulatory issues can create obstacles for drug development.
Goldman B. J Natl Cancer Inst. 2004 Nov 3; 96(21):1573-4.
FDA: approval of generic drug reversed by U.S. Court of Appeals. [J Law Med Ethics. 2002]
FDA: approval of generic drug reversed by U.S. Court of Appeals.
Beliveau S. J Law Med Ethics. 2002 Spring; 30(1):120-2.
Review Notification vs approval. [Ocul Surf. 2007]
Review Notification vs approval.
Novack GD. Ocul Surf. 2007 Jul; 5(3):255-8.
Review Development of new drugs for chemoprophylaxis of malaria. [Med Trop (Mars). 2001]
Review Development of new drugs for chemoprophylaxis of malaria.
Milhous WK. Med Trop (Mars). 2001; 61(1):48-50.

Review Induced pluripotent stem cells as a model for accelerated patient- and disease-specific drug discovery. [Curr Med Chem. 2010]
Review Induced pluripotent stem cells as a model for accelerated patient- and disease-specific drug discovery.
Gunaseeli I, Doss MX, Antzelevitch C, Hescheler J, Sachinidis A. Curr Med Chem. 2010; 17(8):759-66.
Review ADDME--Avoiding Drug Development Mistakes Early: central nervous system drug discovery perspective. [BMC Neurol. 2009]
Review ADDME--Avoiding Drug Development Mistakes Early: central nervous system drug discovery perspective.
Tsaioun K, Bottlaender M, Mabondzo A, Alzheimer's Drug Discovery Foundation. BMC Neurol. 2009 Jun 12; 9 Suppl 1:S1. Epub 2009 Jun 12.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Obstacles and opportunities in new drug development.
Obstacles and opportunities in new drug development.
Clin Pharmacol Ther. 2008 Feb ;83(2):210-2.

PubMed
Applications of cytotoxicity assays and pre-lethal mechanistic assays for assess...
Applications of cytotoxicity assays and pre-lethal mechanistic assays for assessment of human hepatotoxicity potential.
Chem Biol Interact. 2004 Nov 1 ;150(1):115-28.

PubMed
Application of a high-content multiparameter cytotoxicity assay to prioritize co...
Application of a high-content multiparameter cytotoxicity assay to prioritize compounds based on toxicity potential in humans.
J Biomol Screen. 2008 Jul ;13(6):527-37. Epub 2008 Jun 19 .

PubMed
The significance of mitochondrial toxicity testing in drug development.
The significance of mitochondrial toxicity testing in drug development.
Drug Discov Today. 2007 Sep ;12(17-18):777-85. Epub 2007 Aug 22 .

PubMed
Retinitis pigmentosa.
Retinitis pigmentosa.
Lancet. 2006 Nov 18 ;368(9549):1795-809.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed